Author:
Yáñez-Castillo Y. M.,Melgarejo-Segura M. T.,Funes-Padilla C.,Folgueral-Corral M. E.,García-Larios J. V.,Arrabal-Polo M. A.,De Haro Muñoz T.,Arrabal-Martín M.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference18 articles.
1. Barisiene M, Bakavicius A, Stanciute D et al (2020) Prostate health index and prostate health index density as diagnostic tools for improved prostate cancer detection. Biomed Res Int 2020:9872146
2. Chen H, Shi B, Wu Y et al (2022) The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone. Int Urol Nephrol 54:749–756
3. De Luca S, Passera R, Fiori C et al (2015) Prostate health index and prostate cancer gene 3 score but not percent-free prostate specific antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. Urol Oncol 33(424):e17-23
4. Dolejsova O, Kucera R, Fuchsova R et al (2018) The ability of prostate health index (PHI) to predict gleason score in patients with prostate cancer and discriminate patients between gleason score 6 and gleason score higher than 6-a study on 320 patients after radical prostatectomy. Technol Cancer Res Treat 17:1533033818787377
5. Filella X, Foj L, Alcover J et al (2014) The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 μg/L. Clin Chim Acta 436:303–307
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献